Pharmacology of Medical Cannabis.
Adv Exp Med Biol. 2019;1162:151-165. doi: 10.1007/978-3-030-21737-2_8.
Adv Exp Med Biol. 2019.
PMID: 31332738
Review.
The predominant psychotropic component is delta(9)-tetrahydrocannabinol (delta(9)-THC), while the major non-psychoactive ingredient is cannabidiol (CBD). These compounds have been shown to be partial agonists or antagonists at the prototypical cannabinoid receptors, CB1 an …
The predominant psychotropic component is delta(9)-tetrahydrocannabinol (delta(9)-THC), while the major non-psychoactive ingredient is ca …